To further elucidate the possible prognostic value of AFTPH expression in BRCA, DLBC, LUSC, and PAAD, Kaplan–Meier survival curves produced by GEPIA, UALCAN, and Kaplan–Meier plotter were used to compare survival between patients with low AFTPH expression and patients with high AFTPH expression. This evidence concerns the gene AFTPH and pancreatic adenocarcinoma.